Related Experiment Video
Updated: Mar 24, 2026
04:18
Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
Published on: October 10, 2025
650
Perinatal group B streptococcal infection in midgestation.
Pediatric Pathology
|January 1, 1986
Summary
Group B Streptococcus (GBS) infection poses a significant risk for midgestation fetal loss. Early detection and intervention in high-risk pregnancies are crucial to prevent perinatal GBS complications.
Area of Science:
- Perinatal Medicine
- Infectious Diseases
- Obstetrics
Background:
- Group B Streptococcus (GBS) is a leading cause of neonatal infections.
- GBS infections during pregnancy can lead to severe fetal and neonatal outcomes, including death.
- Current management often focuses on late-term GBS screening and treatment.
Purpose of the Study:
- To investigate the impact of GBS infection in midgestation (18-28 weeks).
- To identify risk factors associated with GBS-related perinatal loss.
- To emphasize the need for earlier GBS surveillance in high-risk pregnancies.
Main Methods:
- Autopsy study of 32 fetuses and neonates.
- Isolation of GBS from blood or lung tissue.
- Review of maternal clinical features and pregnancy history.
Main Results:
- GBS was isolated in 34% of cases, with 11 cases occurring in midgestation (all <1000g).
- Maternal complications included vaginal hemorrhage and premature rupture of membranes.
- A 45% fetal death rate was observed in midgestation GBS infections.
- Previous reproductive loss was a significant risk factor for GBS-related perinatal loss.
Conclusions:
- GBS infection in midgestation is associated with a high rate of fetal death.
- Previous pregnancy loss increases the risk of subsequent GBS-related perinatal loss.
- Attention to GBS in high-risk pregnancies should extend to midgestation, not just the third trimester.
Related Concept Videos
01:28Development of the Oral Microbiota
10
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
10
01:30Development of Human Microbiota
11
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
11
01:20Pathophysiology of Diabetes
4.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.3K
01:22Development of Immunocompetence
1.1K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
01:07Teratogenicity
4.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K